45,552 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. purchased a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) in the third quarter, HoldingsChannel reports. The institutional investor purchased 45,552 shares of the company’s stock, valued at approximately $1,469,000.

Several other hedge funds also recently modified their holdings of SGRY. Vanguard Group Inc. lifted its holdings in shares of Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock valued at $223,099,000 after buying an additional 61,400 shares during the period. Clearbridge Investments LLC raised its position in Surgery Partners by 1.3% in the second quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock worth $132,880,000 after acquiring an additional 73,007 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its holdings in Surgery Partners by 47.7% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after acquiring an additional 1,520,484 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Surgery Partners by 26.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock valued at $66,643,000 after purchasing an additional 589,499 shares in the last quarter. Finally, Janus Henderson Group PLC grew its stake in shares of Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after purchasing an additional 2,473,282 shares during the last quarter.

Surgery Partners Stock Down 1.5 %

NASDAQ:SGRY opened at $23.01 on Friday. The business’s fifty day moving average price is $29.86 and its 200 day moving average price is $28.35. The firm has a market capitalization of $2.92 billion, a price-to-earnings ratio of -47.94, a PEG ratio of 19.44 and a beta of 2.76. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 1-year low of $21.36 and a 1-year high of $36.92.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Surgery Partners’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.15 EPS. On average, sell-side analysts forecast that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. KeyCorp assumed coverage on shares of Surgery Partners in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada cut their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday. UBS Group assumed coverage on Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 price objective for the company. Citigroup cut their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Surgery Partners presently has a consensus rating of “Moderate Buy” and a consensus price target of $38.71.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.